Package 60429-354-30

{"route": ["ORAL"], "spl_id": "445d3e2e-7b0c-29ad-e063-6394a90a8ce0", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199147", "349491"], "spl_set_id": ["f3637209-303e-4232-ae79-07315a990973"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Golden State Medical Supply, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (60429-354-30)", "package_ndc": "60429-354-30", "marketing_start_date": "20111202"}], "brand_name": "LAMIVUDINE", "product_id": "60429-354_445d3e2e-7b0c-29ad-e063-6394a90a8ce0", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "60429-354", "generic_name": "lamivudine", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMIVUDINE", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA091606", "marketing_category": "ANDA", "marketing_start_date": "20111202", "listing_expiration_date": "20261231"}